Literature DB >> 27475673

Multi-institutional Validation Study of Commercially Available Deformable Image Registration Software for Thoracic Images.

Noriyuki Kadoya1, Yujiro Nakajima2, Masahide Saito2, Yuki Miyabe3, Masahiko Kurooka4, Satoshi Kito5, Yukio Fujita6, Motoharu Sasaki7, Kazuhiro Arai8, Kensuke Tani9, Masashi Yagi10, Akihisa Wakita11, Naoki Tohyama12, Keiichi Jingu2.   

Abstract

PURPOSE: To assess the accuracy of the commercially available deformable image registration (DIR) software for thoracic images at multiple institutions. METHODS AND MATERIALS: Thoracic 4-dimensional (4D) CT images of 10 patients with esophageal or lung cancer were used. Datasets for these patients were provided by DIR-lab (dir-lab.com) and included a coordinate list of anatomic landmarks (300 bronchial bifurcations) that had been manually identified. Deformable image registration was performed between the peak-inhale and -exhale images. Deformable image registration error was determined by calculating the difference at each landmark point between the displacement calculated by DIR software and that calculated by the landmark.
RESULTS: Eleven institutions participated in this study: 4 used RayStation (RaySearch Laboratories, Stockholm, Sweden), 5 used MIM Software (Cleveland, OH), and 3 used Velocity (Varian Medical Systems, Palo Alto, CA). The ranges of the average absolute registration errors over all cases were as follows: 0.48 to 1.51 mm (right-left), 0.53 to 2.86 mm (anterior-posterior), 0.85 to 4.46 mm (superior-inferior), and 1.26 to 6.20 mm (3-dimensional). For each DIR software package, the average 3-dimensional registration error (range) was as follows: RayStation, 3.28 mm (1.26-3.91 mm); MIM Software, 3.29 mm (2.17-3.61 mm); and Velocity, 5.01 mm (4.02-6.20 mm). These results demonstrate that there was moderate variation among institutions, although the DIR software was the same.
CONCLUSIONS: We evaluated the commercially available DIR software using thoracic 4D-CT images from multiple centers. Our results demonstrated that DIR accuracy differed among institutions because it was dependent on both the DIR software and procedure. Our results could be helpful for establishing prospective clinical trials and for the widespread use of DIR software. In addition, for clinical care, we should try to find the optimal DIR procedure using thoracic 4D-CT data.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27475673     DOI: 10.1016/j.ijrobp.2016.05.012

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

1.  Quadratic penalty method for intensity-based deformable image registration and 4DCT lung motion recovery.

Authors:  Edward Castillo
Journal:  Med Phys       Date:  2019-03-14       Impact factor: 4.071

2.  Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams.

Authors:  Oleg N Vassiliev; Christine B Peterson; Joe Y Chang; Radhe Mohan
Journal:  J Radiother Pract       Date:  2020-10-16

3.  CALIPER: A deformable image registration algorithm for large geometric changes during radiotherapy for locally advanced non-small cell lung cancer.

Authors:  Christopher L Guy; Elisabeth Weiss; Gary E Christensen; Nuzhat Jan; Geoffrey D Hugo
Journal:  Med Phys       Date:  2018-04-16       Impact factor: 4.071

4.  Comparison of rigid and deformable image registration for nasopharyngeal carcinoma radiotherapy planning with diagnostic position PET/CT.

Authors:  Yudai Kai; Hidetaka Arimura; Ryo Toya; Tetsuo Saito; Tomohiko Matsuyama; Yoshiyuki Fukugawa; Shinya Shiraishi; Yoshinobu Shimohigashi; Masato Maruyama; Natsuo Oya
Journal:  Jpn J Radiol       Date:  2019-12-13       Impact factor: 2.374

5.  Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR.

Authors:  Narges Kazemzadeh; Arezoo Modiri; Santanu Samanta; Yulong Yan; Ross Bland; Timothy Rozario; Henky Wibowo; Puneeth Iyengar; Chul Ahn; Robert Timmerman; Amit Sawant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-02       Impact factor: 7.038

6.  Clinical use, challenges, and barriers to implementation of deformable image registration in radiotherapy - the need for guidance and QA tools.

Authors:  Mohammad Hussein; Adeyemi Akintonde; Jamie McClelland; Richard Speight; Catharine H Clark
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.039

7.  Rigid and Deformable Image Registration for Radiation Therapy: A Self-Study Evaluation Guide for NRG Oncology Clinical Trial Participation.

Authors:  Yi Rong; Mihaela Rosu-Bubulac; Stanley H Benedict; Yunfeng Cui; Russell Ruo; Tanner Connell; Rojano Kashani; Kujtim Latifi; Quan Chen; Huaizhi Geng; Jason Sohn; Ying Xiao
Journal:  Pract Radiat Oncol       Date:  2021-03-02

8.  Using 4D dose accumulation to calculate organ-at-risk dose deviations from motion-synchronized liver and lung tomotherapy treatments.

Authors:  William S Ferris; Edward H Chao; Jennifer B Smilowitz; Randall J Kimple; John E Bayouth; Wesley S Culberson
Journal:  J Appl Clin Med Phys       Date:  2022-04-29       Impact factor: 2.243

Review 9.  Dose Summation Strategies for External Beam Radiation Therapy and Brachytherapy in Gynecologic Malignancy: A Review from the NRG Oncology and NCTN Medical Physics Subcommittees.

Authors:  Hayeon Kim; Yongsook C Lee; Stanley H Benedict; Brandon Dyer; Michael Price; Yi Rong; Ananth Ravi; Eric Leung; Sushil Beriwal; Mark E Bernard; Jyoti Mayadev; Jessica R L Leif; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-06-17       Impact factor: 7.038

10.  Development of a physical geometric phantom for deformable image registration credentialing of radiotherapy centers for a clinical trial.

Authors:  Noriyuki Kadoya; Siwaporn Sakulsingharoj; Tomas Kron; Adam Yao; Nicholas Hardcastle; Alanah Bergman; Hiroyuki Okamoto; Nobutaka Mukumoto; Yujiro Nakajima; Keiichi Jingu; Mitsuhiro Nakamura
Journal:  J Appl Clin Med Phys       Date:  2021-06-22       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.